Clinical Trials Logo

Clinical Trial Summary

Bronchopulmonary cancer is the first cause of mortality in the world. We want to update the margins used in stereotactic radiotherapy, in the context of localized lung cancer, of non-surgical management. The investigators wish to redefine the stereotactic radiotherapy margins according to the histological type in localized non-small cell lung cancer. Indeed, these criteria were previously defined on a smaller cohort, in the context of 3D radiotherapy (mainly T3, T4 tumors). In addition, the incidence of radiation pneumonitis is highly dependent on the irradiated lung volume, which in turn depends on the CTV margins used.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05605236
Study type Observational
Source University Hospital, Strasbourg, France
Contact
Status Completed
Phase
Start date February 16, 2020
Completion date July 16, 2022

See also
  Status Clinical Trial Phase
Completed NCT04802902 - Feasibility of Immunotherapy Plus Chemotherapy Administration to Patients With Bronchial Cancer in a Hospital-at- Home Setting
Completed NCT04334239 - Effectiveness of Care in Certified Cancer Centres in Germany
Completed NCT03328559 - Kinetics of Circulating Tumoral Cells in Bronchial Primitive Cancer N/A
Completed NCT03786653 - Feasibility of Immunotherapy Administration to Patients With Bronchial Cancer in a Hospital-at- Home Setting (ImHADom)
Recruiting NCT05886075 - A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Advanced Solid Tumors Early Phase 1
Completed NCT05027490 - CAncer, NUtrition and Taste 2 N/A
Not yet recruiting NCT02648087 - Prevalence of Sleep-disordered Breathing in Patients With a Newly Diagnosed Non Small Cell Lung Cancer N/A
Completed NCT03684486 - Rehabilitation by Effort for Patients With Advanced Bronchial Cancer N/A
Active, not recruiting NCT02877043 - Study of the Quality of Lung Resection N/A